PeptidePedia The community reference

Glucose-dependent insulinotropic polypeptide: difference between revisions

Diff·revision 49 → 50·08:22, 21 Aug 2025

Difference between revision 49 and revision 50 of Glucose-dependent insulinotropic polypeptide. 2 lines changed; the page grew by 427 bytes.

Revision 49 — 20:31, 7 Aug 2025
NavboxNiko (talk)
cite the trial publication rather than the press release
7,838 bytes ±0
Revision 50 — 08:22, 21 Aug 2025
HyphenHarriet (talk)
fix hyphenation per PP:MOS
8,265 bytes +427
44GIP remained therapeutically unexploited for decades because insulinotropic beta-cell responses were thought to be lost in diabetes; the development of [[GLP-1 receptor agonist|GLP-1-directed monotherapy]] proceeded from that understanding. Dual GIP/GLP-1 receptor agonists ([[tirzepatide]], [[retatrutide]]) have demonstrated superior glycaemic control and weight loss compared to GLP-1 monotherapy in phase 3 trials, and are now approved or in development for both type 2 diabetes and obesity.{{r|frias2021,frias2022}}44GIP remained therapeutically unexploited for decades because insulinotropic beta-cell responses were thought to be lost in diabetes; the development of [[GLP-1 receptor agonist|GLP-1-directed monotherapy]] proceeded from that understanding. Dual GIP/GLP-1 receptor agonists ([[tirzepatide]], [[retatrutide]]) have demonstrated superior glycaemic control and weight loss compared to GLP-1 monotherapy in phase 3 trials, and are now approved or in development for both type 2 diabetes and obesity.{{r|frias2021,frias2022}}
4545
+46The mechanisms underlying dual-agonist superiority are incompletely understood. Hypotheses include restoration of beta-cell GIP responsiveness through ambient GLP-1 signalling, adipose-tissue effects of dual agonism, and effects on the [[Arcuate nucleus|feeding centre]] in the hypothalamus. The GIP effect appears to be weight-loss dependent rather than independent, suggesting complementary rather than additive mechanisms.
+47
46== References ==48== References ==
47{{reflist}}49{{reflist}}